HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$124.83
Tradestie Score
40
Market Cap
$8.77B
P/E Ratio
35.8
Revenue Growth
0.5%
Analyst Upside
-12.9%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$113.44
|
$16.93B | 14.9 | 76 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$62.15
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.83
|
$15.22B | - | 49 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$141.31
|
$13.59B | 20.8 | 59 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.90
|
$12.36B | 17.6 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.58
|
$11.09B | 20.3 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.80
|
$10.76B | - | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$245.81
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.21
|
$10.53B | 152.5 | 72 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.27
|
$10.49B | - | 69 | Compare |
More HALO Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry